tetano
Editor, Senior Moderator
Int J Antimicrob Agents. 2020 Apr 9:105969. doi: 10.1016/j.ijantimicag.2020.105969. [Epub ahead of print]
Drug repositioning an alternative for the treatment of coronavirus COVID-19.
Serafin MB[SUP]1[/SUP], Bottega A[SUP]1[/SUP], Foletto VS[SUP]1[/SUP], da Rosa TF[SUP]1[/SUP], H?rner A[SUP]2[/SUP], H?rner R[SUP]3[/SUP].
Author information
Abstract
Given the extreme importance of the current pandemic caused by COVID-19, and due to the fact that scientists agree that there is no identified pharmacological treatment where possible therapeutic alternatives are raised through drug repositioning. We present a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-Cov, with potential use in the treatment of COVID-19 disease.
Copyright ? 2020 Elsevier Ltd. All rights reserved.
KEYWORDS:
COVID-19; Repositioning; SARS-CoV-2
PMID:32278811DOI:10.1016/j.ijantimicag.2020.105969
Drug repositioning an alternative for the treatment of coronavirus COVID-19.
Serafin MB[SUP]1[/SUP], Bottega A[SUP]1[/SUP], Foletto VS[SUP]1[/SUP], da Rosa TF[SUP]1[/SUP], H?rner A[SUP]2[/SUP], H?rner R[SUP]3[/SUP].
Author information
Abstract
Given the extreme importance of the current pandemic caused by COVID-19, and due to the fact that scientists agree that there is no identified pharmacological treatment where possible therapeutic alternatives are raised through drug repositioning. We present a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-Cov, with potential use in the treatment of COVID-19 disease.
Copyright ? 2020 Elsevier Ltd. All rights reserved.
KEYWORDS:
COVID-19; Repositioning; SARS-CoV-2
PMID:32278811DOI:10.1016/j.ijantimicag.2020.105969